Patents by Inventor David Markby

David Markby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140080810
    Abstract: The invention is directed to Compounds of Formula I: (I) and pharmaceutically acceptable salts or solvates thereof, as well as methods of treating using the compounds, methods for screening for inhibitor compounds and methods for identifying treatment regimens.
    Type: Application
    Filed: November 15, 2011
    Publication date: March 20, 2014
    Applicant: Exelixis, Inc.
    Inventors: Kenneth D. Rice, David Markby
  • Publication number: 20140066431
    Abstract: The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as well as methods of treating using the compounds, methods for screening for inhibitor compounds and methods for identifying treatment regimens.
    Type: Application
    Filed: November 15, 2011
    Publication date: March 6, 2014
    Applicant: Exelixis, Inc.
    Inventors: Kenneth D. Rice, David Markby
  • Publication number: 20040087783
    Abstract: The present invention relates to SAD polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for SAD related diseases or conditions characterized by an abnormal interaction between a SAD polypeptide and a SAD binding partner.
    Type: Application
    Filed: April 22, 2002
    Publication date: May 6, 2004
    Applicant: SUGEN, Inc.
    Inventors: Gregory D. Plowman, Susan Onrust, David Markby, Sara Courtneidge
  • Patent number: 6388063
    Abstract: The present invention relates to SAD polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for SAD related diseases or conditions characterized by an abnormal interaction between a SAD polypeptide and a SAD binding partner.
    Type: Grant
    Filed: June 17, 1998
    Date of Patent: May 14, 2002
    Assignee: Sugen, Inc.
    Inventors: Gregory D. Plowman, Susan Onrust, David Markby, Sara Courtneidge